Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')
K Solez, R B Colvin, L C Racusen, B Sis, P F Halloran, P E Birk, P M Campbell, M Cascalho, A B Collins, A J Demetris, C B Drachenberg, I W Gibson, P C Grimm, M Haas, E Lerut, H Liapis, R B Mannon, P B Marcus, M Mengel, M J Mihatsch, B J Nankivell, V Nickeleit, J C Papadimitriou, J L Platt, P Randhawa, I Roberts, L Salinas-Madriga, D R Salomon, D Seron, M Sheaff, J J Weening, K Solez, R B Colvin, L C Racusen, B Sis, P F Halloran, P E Birk, P M Campbell, M Cascalho, A B Collins, A J Demetris, C B Drachenberg, I W Gibson, P C Grimm, M Haas, E Lerut, H Liapis, R B Mannon, P B Marcus, M Mengel, M J Mihatsch, B J Nankivell, V Nickeleit, J C Papadimitriou, J L Platt, P Randhawa, I Roberts, L Salinas-Madriga, D R Salomon, D Seron, M Sheaff, J J Weening
Abstract
The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15-21 July 2005. Major outcomes included the elimination of the non-specific term "chronic allograft nephropathy" (CAN) from the Banff classification for kidney allograft pathology, and the recognition of the entity of chronic antibody-mediated rejection. Participation of B cells in allograft rejection and genomics markers of rejection were also major subjects addressed by the conference.
Source: PubMed